Search Tag: MASH
2026 03 Jun
MASLD/MASH is moving up Europe’s liver health agenda as its clinical burden rises alongside obesity, type 2 diabetes and broader cardiometabolic risk. A recent analysis published in The Lancet Regional Health – Europe assesses how ready the 27 European Union countries and the United Kingdom are to address metabolic dysfunction-associated st1Read more
2026 03 Jun
MASLD/MASH is moving up Europe’s liver health agenda as its clinical burden rises alongside obesity, type 2 diabetes and broader cardiometabolic risk. A recent analysis published in The Lancet Regional Health – Europe assesses how ready the 27 European Union countries and the United Kingdom are to address metabolic dysfunction-associated st1Read more
2026 02 Apr
Curve Biosciences , the Whole-Body Intelligence™ company, today announced the appointment of Amit Singal, M.D., as Chief Medical Officer. A nationally recognized leader in clinical management of liver diseases like cirrhosis, hepatocellular carcinoma, and MASH, Dr. Singal brings deep clinical expertise, translational research leadership, and deca1Read more
2025 07 May
New research published in the New England Journal of Medicine reveals that semaglutide effectively treats liver disease in nearly two-thirds of patients, offering new hope for those with metabolic dysfunction-associated steatohepatitis (MASH), a severe form of liver disease. MASH is a progressive form of Metabolic dysfunction-associated 1Read more
2024 23 Jul
An overview of a new tool that converts highly validated ultrasound technology into a software-based application, enabling any clinician to assess and quantify liver stiffness at the point of care and democratise liver assessment—a critical need in light of the increasing prevalence and care burden of MASLD and MASH worldwide. 1Read more